Zobrazeno 1 - 10
of 23
pro vyhledávání: '"N. Strigl-Pill"'
Publikováno v:
American Journal of Medical Genetics Part C: Seminars in Medical Genetics. :80-88
Pompe disease (glycogen storage disease type 2 or acid maltase deficiency) is a rare autosomal recessive lysosomal storage disorder. Since the advent of ERT a lot has been learned about the phenotypic spectrum especially in the late onset patients. W
Autor:
Wolfram Kress, Josef Müller-Höcker, Peter Schneiderat, Benedikt Schoser, Nicolai Schramm, Joachim Weis, N. Strigl-Pill, Hanns Lochmüller, Maggie C. Walter, Andreas Ferbert, Sabine Rudnik-Schöneborn, Peter Reilich, Johannes Noth
Publikováno v:
Journal of Neurology. 257:1108-1118
Facioscapulohumeral muscular dystrophy (FSHD) is the third most common muscular dystrophy and usually follows an autosomal dominant trait. Clinically, FSHD affects facial muscles and proximal upper limb and girdle muscles, but may present with variab
Autor:
Beate Schlotter-Weigel, Benedikt Schoser, Maggie C. Walter, Peter Reilich, M. Schuberth, Peter Schneiderat, N. Strigl-Pill, Joachim Schessl
Publikováno v:
Journal of Neurology. 258:946-947
Paraneoplastic cerebellar degeneration (PCD) is a rare heterogeneous group of disorders associated with cancer and anti-neuronal antibodies. Patients display symptoms reflecting cerebellar dysfunction including dysarthria, severe ataxia and abnormal
Autor:
N Strigl-Pill
Publikováno v:
Klinische Neurophysiologie. 41
Autor:
C. Wessig, M. Spranger, A. Brejova, Cornelia Kornblum, Eugen Mengel, Max J. Hilz, B. Grunert, Karlheinz Reiners, N. Strigl-Pill, Stefan Vielhaber, F. Breunig, S. Strothotte, F.X. Glocker, K. Eger, Benedikt Schoser, Wolfgang Müller-Felber, Marcus Deschauer
Publikováno v:
Journal of neurology. 257(1)
Late-onset glycogen storage disease type 2 (GSD2)/Pompe disease is a progressive multi-system disease evoked by a deficiency of lysosomal acid alpha-glucosidase (GAA) activity. GSD2 is characterized by respiratory and skeletal muscle weakness and atr
Autor:
Angela Abicht, Ulrike Schara, Nina Barišić, Marcus Deschauer, Volker Straub, Juliane S. Müller, Hanns Lochmüller, M. Wendt, N. Strigl-Pill, Christopher Lindberg
In congenital myasthenic syndrome with DOK7 mutations ephedrine was reported to be beneficial in single patients. We carried out a small, open and prospective cohort study in eight European patients manifesting from birth to 12 years. Five patients s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db463a1c6dfc488b6582c232ca93fb8e
https://www.ncbi.nlm.nih.gov/pubmed/19837590
https://www.ncbi.nlm.nih.gov/pubmed/19837590
Publikováno v:
Aktuelle Neurologie. 35
Autor:
M. Schröder, N. Strigl-Pill, M Spaeth, Wolfgang Müller-Felber, Benedikt Schoser, A. König, H. Beranek, Dieter Pongratz
Publikováno v:
European journal of neurology. 13(2)
The distinction between multifocal motor neuropathy, treatable by intravenous immunoglobulins (IVIg), and degenerative motor neurone disorders is often difficult. To find predictive factors for the response to IVIg treatment, 40 consecutive patients
Autor:
Angela Abicht, Hanns Lochmüller, Ulrike Schara, N. Strigl-Pill, M. Wendt, Juliane Müller, Marcus Deschauer
Publikováno v:
Neuromuscular Disorders. 17:818-819
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.